You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 3.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-04-30 | n/a | -2.83 | -1.06p | -25.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-04-30 | n/a | -3.03 | -1.14p | -14.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | n/a | -4.50 | -1.36p | -9.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | n/a | -4.94 | -1.34p | -9.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | n/a | -6.71 | -1.45p | -3.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | 0.00 | -7.44 | -1.35p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-04-30 | 0.00 | -7.42 | -1.30p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2022-04-30 | 0.00 | -5.91 | -1.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Scancell's 'SCIB1' clears latest regulatory hurdle in US Sharecast News | 03 Feb |
|---|---|
| Scancell inks AvidiMab agreement with Chinese biotech company Sharecast News | 16 Dec |
| Scancell signs collaboration agreement with antibody technology company Sharecast News | 04 Sep |
| SCIB1 IND Application Approved | 03-Feb-20 07:06 |
|---|---|
| Interim Results | 31-Jan-20 07:05 |
| Third agreement signed for antibody platform | 20-Jan-20 07:05 |
| Director's Dealings | 17-Dec-19 12:46 |
| Second agreement signed for AvidiMab platform | 16-Dec-19 07:01 |